Pei, Dongling
Ma, Zeyu
Qiu, Yuning
Wang, Minkai
Wang, Zilong
Liu, Xianzhi
Zhang, Long
Zhang, Zhenyu
Li, Ran
Yan, Dongming
Funding for this research was provided by:
National Natural Science Foundation of China (82273493, 82173090)
National Program for Postdoctoral Researchers (GZC20232416)
Postdoctoral Research Fund of the First Affiliated Hospital of Zhengzhou University (72127)
Henan Provincial Medical Science and Technology Research Program Joint Construction Project (LHGI20240203)
Key Program of Medical Science and Technique Foundation of Henan Province (242102311107)
Article History
Received: 5 August 2024
Revised: 15 April 2025
Accepted: 18 April 2025
First Online: 8 May 2025
Declarations
:
: The Human Scientific Ethics Committee at the First Affiliated Hospital of Zhengzhou University approved this research project (No. 2019-KY-176). All the steps of procedures were implemented in conformity with the relevant guidelines and regulatory requirements set forth by the First Affiliated Hospital of Zhengzhou University. All the protocols for animal experiments were sanctioned by the First affiliated Hospital of Zhengzhou University Animal Welfare Committee (No. 2021090201). The experimental procedures adhered strictly to the guidelines set forth in the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Informed consent was secured from the patients whose fresh tumor specimens were utilized for mRNA-sequencing, RT-qPCR, IHC, and western blotting. And informed consent statement was obtained for patients who agree to receive MRI scans.
: Not applicable.
: The authors declare that they have no competing interests.